Clinical trial
International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions With Myocardial Ischemia - ISCHEMIA-CTO Trial
NCT03563417 is registered in ClinicalTrials.gov with Aarhus University Hospital Skejby as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions With Myocardial Ischemia - ISCHEMIA-CTO Trial
- Lead sponsor
- Aarhus University Hospital Skejby
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 6, 2018
- Completion date
- November 1, 2032
- Enrollment
- 1,560 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
chronic total occlusion of coronary artery, ischemic heart disease